Chair(s): Silke Van Koningsbruggen-Rietschel, Nicholas Simmonds
Session type: Pro and con debate
Gwyneth Davies
Session content
Better outcomes with CFTR-modulators - Stopping symptomatic pulmonary therapies is justified - PRO
Gwyneth Davies
Replay
Slides
Dorota Sands
Slides
Replay
Dorota Sands
Replay
Carlo Castellani
Slides
Replay
Carlo Castellani
Replay
Session aims
To understand the changing landscape with CFTR modulators; to gain knowledge about the PROs and CONs for stopping symptomatic pulmonary therapies; to become familiar with potential future models of CF care.